Navigation Links
Sun Pharma Extends Tender Offer for Taro
Date:7/14/2008

MUMBAI, India, July 14 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the Expiration Date of the Tender Offer for purchase of all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). The Offer has been extended to 5:00 p.m., New York City time, on Tuesday, September 2, 2008. This extension of the Expiration Date of the Tender Offer was recommended by the Honorable Judge Dr. Michal Agmon-Gonen J. of the Tel-Aviv District Court in order to allow the court to rule on the merits of the litigation commenced against Alkaloida and its affiliates by Taro and certain of its directors regarding the applicability of the special tender offer rules under the Israeli Companies Law to the Offer. Such recommendation for extension was agreed upon by all parties to the litigation.

The Offer was commenced on June 30, 2008 in order to comply with the terms of the Option Agreement between Alkaloida and the controlling shareholders of Taro. Alkaloida exercised its options to acquire shares of Taro from the controlling shareholders on June 25, 2008. The Option Agreement required Alkaloida, promptly after exercising the options, to commence a tender offer at USD 7.75 per Ordinary Share of Taro held by other shareholders. The Offer had previously been scheduled to expire at 12:00 midnight, New York City time, on Monday, July 28, 2008. As of 5:00 p.m., New York City time, on July 11, 2008, 700 Ordinary Shares had been tendered and not withdrawn from the Offer.

Greenhill & Co., LLC is acting as the Dealer Manager for the Tender Offer and MacKenzie is acting as the Information Agent for the Tender Offer.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,
'/>"/>

SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Missouri (PRWEB) October 31, 2014 With ... school, one Midwest optometrist feels they may overlook one ... to affect areas like concentration, school performance and even ... be too brief to identify progressive vision problems, and ... Joseph, Mo., announces a new initiative: The Awesome Eyes ...
(Date:10/31/2014)... News) -- Sleep apnea may make it hard for you ... car or left your house keys, a small study suggests. ... that this ability -- called spatial memory -- was impaired ... when other stages of sleep weren,t affected. REM sleep is ... "We,ve shown for the first time that sleep apnea, ...
(Date:10/31/2014)... that either they or a family member have experienced ... issue of The Gerontological Society of America,s Public ... goes on to show that Americans strongly support holding ... health care wishes. , This PP&AR , titled ... 12 articles that present new ways of understanding the ...
(Date:10/31/2014)... North Shore Eye Care today announced ... Island and the addition of leading ophthalmologist, William S. ... North Shore Eye Care Medical Director, Jeffrey Martin, MD. ... the Department of Ophthalmology of Winthrop-University Hospital and has ... for more than 30 years. He has been named ...
(Date:10/31/2014)... 31, 2014 FindSurrogateMother.com conveys ... gifts of life — building a family through surrogacy. ... mothers and donors with hopeful intended parents in turn ... , It’s a collective aptitude of surrogate mothers, intended ... and fertility clinics that help provide these connections — ...
Breaking Medicine News(10 mins):Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... of thyroid cancer is increasing. In this longitudinal study over ... used the Ontario Cancer Registry to identify 7422 cases of ... the jump in the incidence rate of this type of ... annual increase of 13% per year. , In their ...
... Holiday Parties Merry and Safe for Everyone, CHICAGO, ... with the holidays it,s sometimes easy to forget that ... It can be a time when widespread,availability of alcohol ... younger children may view these parties as,opportunities to sneak ...
... GPRO ) announced today that Jorgine Ellerbrock ... "We are pleased to add Jorgine,s extensive ... already strong senior management team," said,Carl Hull, Gen-Probe,s ... Ellerbrock, 46, joins the Company from Invitrogen Corporation,where ...
... needs are vastly different than men,s way beyond their reproductive ... of cardiovascular disease and are more likely to suffer from ... the differences. , Yet, there,s a cavernous void ... have been done on men and the findings applied to ...
... NEW YORK (Nov. 19, 2007) -- Dr. Bruce McCandliss, ... and associate professor of psychology in psychiatry at Weill ... President of the United States in the form of ... (PECASE). The award is the highest honor bestowed by ...
... appears in the current issue of SCAN (Social Cognitive ... School of Medicine discuss how men and women differ ... , We found that different parts of the brain ... and women when they are faced with performance-related stress, ...
Cached Medicine News:Health News:Holidays Can Present Drinking Opportunities for Teens 2Health News:Holidays Can Present Drinking Opportunities for Teens 3Health News:Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations 2Health News:Women aren't men 2Health News:Women aren't men 3Health News:White House awards Weill Cornell's Bruce McCandliss highest honor for early career scientists 2Health News:Penn researchers use brain imaging to demonstrate how men and women cope differently under stress 2
(Date:10/31/2014)... 3, 2014 British Journal ... BPH to discuss "male orgasmic dysfunction" with their doctor ... treat prostate symptoms while preserving sexual function   ... publication of a paper in the British Journal of ... prostate to discuss with their doctors the likely impact ...
(Date:10/31/2014)... BARCELONA , October 31, 2014 ... two Australian patents of B. Braun Melsungen AG (B. Braun) ... safety IV catheters manufactured by Poly Medicure Ltd ... Australia proceeding number VID 463 of 2013 ... In the detailed judgment, Multigate was found to have infringed ...
(Date:10/31/2014)... 30, 2014 Migranade, Inc. announced today the ... to the 36 million U.S. migraine sufferers November, 2014. ... targets the actual cause of migraines and not just ... not the source Migranade is assured to be a ... Relief is available at http://www.migranade.com and will ...
Breaking Medicine Technology:Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2Game Changing Migraine Medication To Be Available November 2014 2
... 18, 2011 HealthWarehouse.com, Inc. (OTC: HEWA) a leading ... results for the year ended December 31, 2010. ... the Company,s net sales increased $1,908,223 to $5,691,765, up ... was driven by growth in the Company,s prescription business. ...
... CryoLife, Inc. (NYSE: CRY ), an implantable ... announced the expiration of the 20-day "go-shop" period that ... ("Cardiogenesis"), whereby CryoLife is conducting a cash tender offer ... During the "go-shop" period, Cardiogenesis was ...
Cached Medicine Technology:HealthWarehouse.com Reports 278% Year-Over-Year Prescription Growth 2HealthWarehouse.com Reports 278% Year-Over-Year Prescription Growth 3CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 2CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 3CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 4CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 5CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 6CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: